EH3 (ABHD9): The first member of a new epoxide hydrolase family with high activity for fatty acid epoxides

Journal of Lipid Research

Volumn 53, Issue 10, 2012, Pages 2038-2045

  Decker, Martina ^a   Adamska, Magdalena ^a   Cronin, Annette ^a   Di Giallonardo, Francesca ^a   Burgener, Julia ^a   Marowsky, Anne ^a   Falck, John R ^b   Morisseau, Christophe ^c   Hammock, Bruce D ^c   Gruzdev, Artiom ^d   Zeldin, Darryl C ^d   Arand, Michael ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Blood pressure; Diabetes type II; Epoxyeicosatrienoic acid; Pain

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 3; EPOXIDE HYDROLASE 4; FATTY ACID DERIVATIVE; FATTY ACID EPOXIDE DERIVATIVE; LEUKOTOXIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME METABOLISM; HYDROLYSIS; IMMUNOREACTIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; TISSUE DISTRIBUTION;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; EPOXIDE HYDROLASES; EPOXY COMPOUNDS; HUMANS; METABOLIC DETOXICATION, DRUG; MICE; MICE, INBRED C57BL; PHYLOGENY; STEARIC ACIDS; XENOBIOTICS;

EID: 84866150711     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M024448     Document Type: Article

References (46)

1. Oesch, F. 1973. Mammalian epoxide hydrases-inducible enzymes catalyzing inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica. 3: 305-340.
2. Blee, E. 1998. Biosynthesis of phytooxylipins: the peroxygenase pathway. Lipid/Fett. 100: 121-127.
3. Spector, A. A., and A. W. Norris. 2007. Action of epoxyeicosatrienoic acids on cellular function. Am. J. Physiol. Cell Physiol. 292: C996-C1012.
4. Campbell, W. B., D. Gebremedhin, P. F. Pratt, and D. R. Harder. 1996. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-423.
5. Lee, C. R., J. D. Imig, M. L. Edin, J. Foley, L. M. DeGraff, J. A. Bradbury, J. P. Graves, F. B. Lih, J. Clark, P. Myers, et al. 2010. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice. FASEB J. 24: 3770-3781.
6. Conroy, J. L., C. Fang, J. Gu, S. O. Zeitlin, W. Yang, J. Yang, M. A. VanAlstine, J. W. Nalwalk, P. J. Albrecht, J. E. Mazurkiewicz, et al. 2010. Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling. Nat. Neurosci. 13: 284-286.
7. Inceoglu, B., S. L. Jinks, A. Ulu, C. M. Hegedus, K. Georgi, K. R. Schmelzer, K. Wagner, P. D. Jones, C. Morisseau, and B. D. Hammock. 2008. Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. Proc. Natl. Acad. Sci. USA. 105: 18901-18906.
8. Medhora, M., J. Daniels, K. Mundey, B. Fisslthaler, R. Busse, E. R. Jacobs, and D. R. Harder. 2003. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 284: H215-H224.
9. Smith, K. R., K. E. Pinkerton, T. Watanabe, T. L. Pedersen, S. J. Ma, and B. D. Hammock. 2005. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc. Natl. Acad. Sci. USA. 102: 2186-2191.
10. Imig, J. D., and B. D. Hammock. 2009. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat. Rev. Drug Discov. 8: 794-805.
11. Marino, J. P., Jr. 2009. Soluble epoxide hydrolase, a target with multiple opportunities for cardiovascular drug discovery. Curr. Top. Med. Chem. 9: 452-463.
12. Arand, M., A. Cronin, F. Oesch, S. L. Mowbray, and T. A. Jones. 2003. The telltale structures of epoxide hydrolases. Drug Metab. Rev. 35: 365-383.
13. Arand, M., B. M. Hallberg, J. Y. Zou, T. Bergfors, F. Oesch, M. J. van der Werf, J. A. M. de Bont, T. A. Jones, and S. L. Mowbray. 2003. Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site. EMBO J. 22: 2583-2592.
14. Fillgrove, K. L., S. Pakhomova, M. R. Schaab, M. E. Newcomer, and R. N. Armstrong. 2007. Structure and mechanism of the genomically encoded fosfomycin resistance protein, FosX, from Listeria monocytogenes. Biochemistry. 46: 8110-8120.
15. Thunnissen, M. M. G. M., P. Nordlund, and J. Z. Haeggstrom. 2001. Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation. Nat. Struct. Biol. 8: 131-135.
16. Oesch, F. 1974. Purification and specificity of a human microsomal epoxide hydratase. Biochem. J. 139: 77-88.
17. Marowsky, A., J. Burgener, J. R. Falck, J. M. Fritschy, and M. Arand. 2009. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism. Neuroscience. 163: 646-661.
18. Hammock, B. D., S. S. Gill, V. Stamoudis, and L. I. Gilbert. 1976. Soluble mammalian epoxide hydratase-action on juvenile hormone and other terpenoid epoxides Comp. Biochem. Physiol. B. 53: 263-265.
19. Moghaddam, M. F., D. F. Grant, J. M. Cheek, J. F. Greene, K. C. Williamson, and B. D. Hammock. 1997. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat. Med. 3: 562-566.
20. Zeldin, D. C., J. Kobayashi, J. R. Falck, B. S. Winder, B. D. Hammock, J. R. Snapper, and J. H. Capdevila. 1993. Regiofacial and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem. 268: 6402-6407.
21. Krämer, A., H. Frank, F. Setiabudi, F. Oesch, and H. Glatt. 1991. Influence of the level of cytosolic epoxide hydrolase on the induction of sister chromatid exchanges by trans-beta-ethylstyrene 7,8-oxide in human lymphocytes. Biochem. Pharmacol. 42: 2147-2152.
22. Arand, M., D. F. Grant, J. K. Beetham, T. Friedberg, F. Oesch, and B. D. Hammock. 1994. Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins-implication for the potential catalytic mechanism of enzymatic epoxide hydrolysis. FEBS Lett. 338: 251-256.
23. Hammock, B. D., F. Pinot, J. K. Beetham, D. F. Grant, M. E. Arand, and F. Oesch. 1994. Isolation of a putative hydroxyacyl enzyme intermediate of an epoxide hydrolase. Biochem. Biophys. Res. Commun. 198: 850-856.
24. Cronin, A., S. Mowbray, H. Durk, S. Homburg, I. Fleming, B. Fisslthaler, F. Oesch, and M. Arand. 2003. The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase. Proc. Natl. Acad. Sci. USA. 100: 1552-1557.
25. Schägger, H., H. Aquila, and G. Von Jagow. 1988. Coomassie blue-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for direct visualization of polypeptides during electrophoresis. Anal. Biochem. 173: 201-205.
26. Friedberg, T., W. Kissel, M. Arand, and F. Oesch. 1991. Production of site-specific P450 antibodies using recombinant fusion proteins as antigens. Methods Enzymol. 206: 193-201.
27. Burnette, W. N. 1981. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodifi ed nitrocellulose and radiographic detection with antibody and radioiodinated protein. Anal. Biochem. 112: 195-203.
28. Müller, F., M. Arand, H. Frank, A. Seidel, W. Hinz, L. Winkler, K. Hänel, E. Blee, J. K. Beetham, B. D. Hammock, et al. 1997. Visualization of a covalent intermediate between microsomal epoxide hydrolase, but not cholesterol epoxide hydrolase, and their substrates. Eur. J. Biochem. 245: 490-496.
29. Arand, M., W. Hinz, F. Müller, K. Hänel, L. Winkler, A. Mecky, M. Knehr, H. Dürk, H. Wagner, M. Ringhoffer, et al. 1996. Structure and mechanism of soluble epoxide hydrolase and its relation to microsomal epoxide hydrolase. In Control Mechanisms of Carcinogenesis. J. G. Hengstler and F. Oesch, editors. Mainz, Germany. 116-134.
30. Harris, T. R., P. A. Aronov, P. D. Jones, H. Tanaka, M. Arand, and B. D. Hammock. 2008. Identification of two epoxide hydrolases in Caenorhabditis elegans that metabolize mammalian lipid signaling molecules. Arch. Biochem. Biophys. 472: 139-149.
31. Holler, R., M. Arand, A. Mecky, F. Oesch, and T. Friedberg. 1997. The membrane anchor of microsomal epoxide hydrolase from human, rat and rabbit displays an unexpected membrane topology. Biochem. Biophys. Res. Commun. 236: 754-759.
32. Arand, M., A. Cronin, M. Adamska, and F. Oesch. 2005. Epoxide hydrolases: structure, function, mechanism, and assay. Methods Enzymol. 400: 569-588.
33. de Medina, P., M. R. Paillasse, G. Segala, M. Poirot, and S. Silvente-Poirot. 2010. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands. Proc. Natl. Acad. Sci. USA. 107: 13520-13525.
34. Arand, M., H. Hemmer, H. Durk, J. Baratti, A. Archelas, R. Furstoss, and F. Oesch. 1999. Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase. Biochem. J. 344: 273-280.
35. Pinot, F., D. F. Grant, J. K. Beetham, A. G. Parker, B. Borhan, S. Landt, A. D. Jones, and B. D. Hammock. 1995. Molecular and biochemical evidence for the involvement of the Asp-333-His-523 pair in catalytic mechanism of soluble epoxide hydrolase. J. Biol. Chem. 270: 7968-7974.
36. Parrish, A. R., G. Chen, R. C. Burghardt, T. Watanabe, C. Morisseau, and B. D. Hammock. 2009. Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase. Cell Biol. Toxicol. 25: 217-225.
37. Ala, U., R. M. Piro, E. Grassi, C. Damasco, L. Silengo, M. Oti, P. Provero, and F. Di Cunto. 2008. Prediction of human disease genes by human-mouse conserved coexpression analysis. PLOS Comput. Biol. 4: e1000043.
38. Morisseau, C., M. H. Goodrow, D. Dowdy, J. Zheng, J. F. Greene, J. R. Sanborn, and B. D. Hammock. 1999. Potent urea and carbamate inhibitors of soluble epoxide hydrolases. Proc. Natl. Acad. Sci. USA. 96: 8849-8854.
39. De Taeye, B. M., C. Morisseau, J. Coyle, J. W. Covington, A. Luria, J. Yang, S. B. Murphy, D. B. Friedman, B. B. Hammock, and D. E. Vaughan. 2010. Expression and regulation of soluble epoxide hydrolase in adipose tissue. Obesity (Silver Spring). 18: 489-498.
40. Yamashita, S., Y. Tsujino, K. Moriguchi, M. Tatematsu, and T. Ushijima. 2006. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 97: 64-71.
41. Cottrell, S., K. Jung, G. Kristiansen, E. Eltze, A. Semjonow, M. Ittmann, A. Hartmann, T. Stamey, C. Haefliger, and G. Weiss. 2007. Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis. J. Urol. 177: 1753-1758.
42. Furuta, J., Y. Nobeyama, Y. Umebayashi, F. Otsuka, K. Kikuchi, and T. Ushijima. 2006. Silencing of peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res. 66: 6080-6086.
43. Panigrahy, D., M. L. Edin, C. R. Lee, S. Huang, D. R. Bielenberg, C. E. Butterfield, C. M. Barnes, A. Mammoto, T. Mammoto, A. Luria, et al. 2012. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J. Clin. Invest. 122: 178-191.
44. Fleming, I. 2007. Epoxyeicosatrienoic acids, cell signaling and angiogenesis. Prostaglandins Other Lipid Mediat. 82: 60-67.
45. Frömel, T., B. Jungblut, J. Hu, C. Trouvain, E. Barbosa-Sicard, R. Popp, S. Liebner, S. Dimmeler, B. D. Hammock, and I. Fleming. 2012. Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols. Proc. Natl. Acad. Sci. USA. 109: 9995-10000.
46. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673-4680.